Skip Nav Destination
You do not currently have access to this content.
A recent workshop discussed characteristics of nonprescription drugs that may be considered “candy-like,” potentially resulting in inadvertent overdose in young children.
Pediatricians encouraged to join FDA workshops on pediatric drug development
September 1, 2024
Topics:
